These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Correlation between disc potency and zone size in temafloxacin activity in vitro. Reggio S; Bassanetti I; Ceralli M; Giardini R; Sansonetti G Drugs Exp Clin Res; 1990; 16(12):611-4. PubMed ID: 2130003 [TBL] [Abstract][Full Text] [Related]
8. [Mechanisms of bacterial resistance to quinolones]. Yoshida H Nihon Saikingaku Zasshi; 1996 Oct; 51(4):973-92. PubMed ID: 8994343 [No Abstract] [Full Text] [Related]
9. [Studies on pyridonecarboxylic acids as antibacterial agents. VI. Synthesis and antibacterial activity of 7-chloro-6-fluoro-1-ethyt-1, 4-dihydro-4-oxopyrido(2,3-c)pyridazine-3-carboxylic acid and derivatives]. Guo HY; Sun LY; Tang Y; Yan GH; Zhang ZP Yao Xue Xue Bao; 1988; 23(8):566-73. PubMed ID: 3151035 [No Abstract] [Full Text] [Related]
10. [Phenotypes of resistance to antibiotics of the most frequently isolated strains in five specialized hospital centers. Multicenter study]. Gabastou JM; Chouaki T; Mangeot J; Zemir A; Manuel C; Lepitre M; Gravisse J; Cornel E; Denis-Jacquot N; Mahuzier G Pathol Biol (Paris); 1995 Apr; 43(4):320-3. PubMed ID: 7567123 [TBL] [Abstract][Full Text] [Related]
11. Development of clinically important resistance to quinolones and other antibiotic groups. Lode H J Int Med Res; 1990; 18 Suppl 4():27D-36D. PubMed ID: 2282967 [TBL] [Abstract][Full Text] [Related]
12. Quinolone resistance in Pseudomonas aeruginosa. Hashmi ZS; Smith JM J Antimicrob Chemother; 1994 Apr; 33(4):881-3. PubMed ID: 8056710 [No Abstract] [Full Text] [Related]
14. Clinical perspectives of quinolone resistance in Pseudomonas aeruginosa. Dalhoff A Antibiot Chemother (1971); 1991; 44():221-39. PubMed ID: 1801641 [No Abstract] [Full Text] [Related]
15. The place of quinolones in bacterial infections. Neu HC Adv Intern Med; 1991; 36():1-32. PubMed ID: 2024577 [TBL] [Abstract][Full Text] [Related]
16. Susceptibility of multiresistant serotype 012 Pseudomonas aeruginosa to fosfomycin in combination with other antibiotics. Watine J; Bourrel C; Dubourdieu B; Gineston JL; Bories P; Durand M; Marre A; Formosa F; Brunel MP; Palliez J Pathol Biol (Paris); 1994 Apr; 42(4):293-5. PubMed ID: 7808781 [TBL] [Abstract][Full Text] [Related]
17. Mutation rates to 4-quinolone resistance. Smith JT Arzneimittelforschung; 1990 Jan; 40(1):65-8. PubMed ID: 2111135 [TBL] [Abstract][Full Text] [Related]
18. [Determining the sensitivity of wound microflora to antiseptics]. Buianov VM; Rodoman GV; Khrupalov AA; Stetsenko EV; Korotaev AL Vestn Khir Im I I Grek; 1990 Oct; 145(10):106-7. PubMed ID: 1964259 [No Abstract] [Full Text] [Related]
19. [Sensitivity of bacterial strains isolated from the urine in relation to type and frequency of use of antibacterial drugs (1972-1975, 1979-1981)]. Wencel J; Mularczyk H Pol Tyg Lek; 1984 Jul; 39(28):951-5. PubMed ID: 6436802 [No Abstract] [Full Text] [Related]
20. [Synthesis and antibacterial activity of 5-amino-6, 8-difluoro-1-(5-fluoro-2-pyridyl)-7-(3-methyl-1-piperazinyl)-1, 4-dihydro-4-oxo-3-quinolinecarboxylic acid and its analogues]. Liu JY; Wei YG; Guo HY Yao Xue Xue Bao; 2001 Jun; 36(6):419-22. PubMed ID: 12585124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]